During the corresponding time, Standard Biotools Inc saw a revenue deteriorated by -7.05 % year on year, sequentially revenue fell by -1 %. While revenue at the Standard Biotools Inc 's corporate clients
Standard Biotools Inc's Comment on Sales, Marketing and Customers
The company operates in the Flow Cytometry, Spatial Biology, and Genomics markets. Flow Cytometry is applied in single-cell analysis, with increasing use in oncology and immunotherapy research. Spatial Biology focuses on tissue imaging and tumor microenvironment studies, primarily within academic and clinical research settings. The Genomics segment encompasses genotyping and gene expression analysis for disease research, pharmacogenomics, personalized medicine, and Next-Generation Sequencing (NGS) sample preparation, supporting biomarker discovery, translational research, and clinical diagnostics. The company partners with original equipment manufacturers (OEMs) to extend its technology into diverse markets. Its customer base includes academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, and companies in biopharmaceuticals, biotechnology, and plant and animal research. Sales and marketing target laboratory directors and principal investigators at academic, translational research, healthcare consortiums, and biopharmaceutical organizations. The sales cycle typically exceeds 12 months due to comprehensive evaluations and tender procedures. Manufacturing facilities are located in Singapore and Canada.
Standard BioTools Purchases Carterra LSA-XT System to Enhance SomaScan PlatformStandard BioTools Inc., a biotechnology company, has recently acquired the LSA-XT system from Carterra, a leading provider of screening and characterization solutions for molecules. The purpose of this purchase is to further validate Standard BioTools SomaScan platform by measuring the kinetic properties of SOMAmer Reagents, providing more accurate information about protein binding and biomarker characterization to its customers.By incorporating the LSA-XT system into its operations, Standard BioTools aims to accelerate data delivery and enhance the validation process for the SomaScan platform. SOMAmer Reagents are short modified...
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue ImagingAdvancements in spatial biology have always been a crucial aspect of medical research, allowing scientists to unravel the intricacies of cellular interactions within tissues. Standard BioTools, a leading provider of cutting-edge bioimaging solutions, has now unveiled a set of innovative high-throughput multiplexed whole slide imaging modalities that are poised to redefine the boundaries of tissue imaging. By combining automation with advanced imaging techniques, these developments aim to revolutionize the field, unlocking new potential for biomedical discoveries.Spatial ...
Standard BioTools and Navignostics recently announced a signif...
Standard Biotools Inc’s Comment on Sales, Marketing and Customers
The company operates in the Flow Cytometry, Spatial Biology, and Genomics markets. Flow Cytometry is applied in single-cell analysis, with increasing use in oncology and immunotherapy research. Spatial Biology focuses on tissue imaging and tumor microenvironment studies, primarily within academic and clinical research settings. The Genomics segment encompasses genotyping and gene expression analysis for disease research, pharmacogenomics, personalized medicine, and Next-Generation Sequencing (NGS) sample preparation, supporting biomarker discovery, translational research, and clinical diagnostics. The company partners with original equipment manufacturers (OEMs) to extend its technology into diverse markets. Its customer base includes academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, and companies in biopharmaceuticals, biotechnology, and plant and animal research. Sales and marketing target laboratory directors and principal investigators at academic, translational research, healthcare consortiums, and biopharmaceutical organizations. The sales cycle typically exceeds 12 months due to comprehensive evaluations and tender procedures. Manufacturing facilities are located in Singapore and Canada.
Sources:
Standard Biotools Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Standard Biotools Inc’s corporate clients.
For your research, we’ve provided 9 tables on Standard Biotools Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
22.01 %